Federal contract award
HHSN26100001
IGF::OT::IGF FISHER BIOSERVICES, INC.; HHSN261201600006I;DTP-16-027; DTP R&D CAN# 8422741; TITLE: REGISTRATION, STORAGEAND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY,EVALUATION AND DEVELOPMENT; PROJECT: NCI-CAR
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NCI |
| NAICS | 541990 — All Other Professional, Scientific, and Technical Services |
| PSC | S215 — Warehousing and Storage Services |
| Parent award / vehicle | HHSN261201600006I |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $11.2M |
| Current contract value | $11.2M |
| Potential contract value / ceiling | $11.2M |
| Start date | Mar 1, 2016 |
| Current end date | Feb 27, 2021 |
| Potential end date | Nov 9, 2023 |
| Latest award activity | Jul 15, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 14 of 14 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 15, 2026 | P00013 | $-8.8K | FY26 UDO INITIATIVE REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY EVALUATION AND DEVELOPMENT |
| Nov 29, 2023 | P00012 | $87.2K | REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY EVALUATION AND DEVELOPMENT |
| Aug 16, 2022 | P00011 | $16.6K | REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY EVALUATION AND DEVELOPMENT |
| Jul 20, 2022 | P00009 | $-15.9K | REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY EVALUATION AND DEVELOPMENT |
| Jul 20, 2022 | P00010 | $0 | REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY EVALUATION AND DEVELOPMENT |
| Jan 26, 2021 | P00008 | $22.7K | PURSUANT TO FAR 43.103(A)(3) AND FAR 52.217-6, THE PURPOSE OF MODIFICATION EIGHT IS TO EXERCISE OPTION FIVE ADDITIONAL EQUIPMENT, ADD FUNDS TO THE TASK ORDER, AND REVISE THE AFFECTED ARTICLES ACCORDINGLY. THE TOTAL TASK ORDER FUNDED AMOUNT IS HE |
| Feb 26, 2020 | P00007 | $2.4M | PURSUANT TO FAR 43.103(A)(3) AND FAR 52.217-9, THE PURPOSE OF MODIFICATION SEVEN IS TO EXERCISE OPTION PERIOD FOUR, ADD FUNDS TO THE TASK ORDER, EXTEND THE PERIOD OF PERFORMANCE AND REVISE THE AFFECTED ARTICLES ACCORDINGLY. THE TOTAL TASK ORDER |
| Jun 19, 2019 | P00006 | $0 | PERIOD OF PERFORMANCE REMAINS UNCHANGED: 03/01/2019 THROUGH 02/29/2020 |
| Feb 27, 2019 | P00005 | $2.3M | IGF::OT::IGF TITLE: REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY, EVALUATION AND DEVELOPMENT; PERIOD OF PERFORMANCE: 03/01/2019 THROUGH 02/29/2020 |
| Jan 18, 2018 | 4 | $2.2M | IGF::OT::IGFTITLE: REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY, EVALUATION AND DEVELOPMENT; PERIOD OF PERFORMANCE: 03/01/2018 THROUGH 02/28/2019 |
| Jul 6, 2017 | 3 | $0 | IGF::OT::IGFTITLE: REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY, EVALUATION AND DEVELOPMENT; PERIOD OF PERFORMANCE: 03/01/2017 THROUGH 02/28/2018 |
| Mar 22, 2017 | 2 | $0 | IGF::OT::IGFTITLE: REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY, EVALUATION AND DEVELOPMENT; PERIOD OF PERFORMANCE: 03/01/2017 THROUGH 02/28/2018 |
| Feb 13, 2017 | 1 | $2.1M | IGF::OT::IGFTITLE: REGISTRATION, STORAGE AND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY, EVALUATION AND DEVELOPMENT; PERIOD OF PERFORMANCE: 03/01/2017 THROUGH 02/28/2018 |
| Feb 26, 2016 | 0 | $2.1M | IGF::OT::IGF FISHER BIOSERVICES, INC.; HHSN261201600006I;DTP-16-027; DTP R&D CAN# 8422741; TITLE: REGISTRATION, STORAGEAND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY,EVALUATION AND DEVELOPMENT; PROJECT: NCI-CAR |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.